Bcl-xL antagonist 2 is a potent, selective, and orally active antagonist of BCL-XL with an IC50 and Ki of 0.091 µM and 65 nM, respectively. Bcl-xL antagonist 2 promotes the apoptosis of cancer cells. Bcl-xL antagonist 2 has the potential for the research of the chronic lymphocytic leukemia (CLL) and non-Hodgkins lymphoma (NHL)[1][2].
Molecular Weight:
436.51
Purity:
98.86
CAS Number:
[1235032-75-3]
Formula:
C21H16N4O3S2
Target:
Apoptosis,Bcl-2 Family
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
